Abstract
Background Hypertension, or elevated blood pressure (BP), is a marker for many cardiovascular diseases and can lead to life-threatening conditions such as heart failure, coronary artery disease, and stroke. BP monitoring using a traditional arm cuff device is often inconvenient and possibly painful in long-term use, i.e. during sleep.
Methods We present a miniature cuffless tonometric finger probe system, that uses the oscillometric method to measure blood pressure (BP). Our approach uses a motorized press that is used to apply pressure to the finger tip to measure BP.
Results We verified the functionality of the device in a clinical trial (n=43) resulting in systolic (SBP) and diastolic (DBP) pressures ((mean ± SD) mmHg) of (−3.5 ± 8.4) mmHg and (−4.0 ± 4.4) mmHg, respectively. Comparison was made with manual auscultation (n=26) and automated cuff oscillometry (n=18). In addition to BP, we demonstrated the ability of the device to assess arterial stiffness (n=18) and detect atrial fibrillation (n=6).
Conclusions We were able to introduce a sufficiently small device that could be used for convenient ambulatory measurements and worn during sleep with minimal discomfort. Lastly, we evaluate methods to further develop the concept and discuss future directions.
Plain language summary Traditional cuff-based automated BP instruments are mainly suitable for individual measurements and are often inconvenient to use. Patients in a hospital ward are typically monitored with many systems and devices. Our aim is to develop a blood pressure measurement technology that could be integrated into a finger-worn pulse oximeter. This way the need for a bulky and inconvenient arm cuff could be eliminated and the number of needed monitoring devices could be reduced. The proposed technology is especially suitable for pseudo-continuous BP measurement, that is, taking automated measurements periodically, enabling BP trend tracking and analysis. In this study, we clinically validate our technology for blood pressure monitoring and further demonstrate its potential to measure arterial stiffness and detect atrial fibrillation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Business Finland, project NO. 1574/31/2018. The work of T. Panula was partly funded by Emil Aaltonen Foundation and The Finnish Foundation for Technology Promotion.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Hospital District of Southwest Finland and National Supervisory Authority for Welfare and Health gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
